Regulation of cathepsin D dependent on the phenotype of colon carcinoma cells

We have studied the intracellular trafficking of cathepsin D in different colon carcinoma cell populations: the HT‐29 cell line, composed of >95% undifferentiated cells; 2 subpopulations derived from this cell line, containing cells committed to differentiation into mucin‐secreting cells (HT‐29 MTX) or enterocyte‐like cells (HT‐29 G−) after confluence; and the Caco‐2 cell line, which spontaneously differentiates into enterocyte‐like cells after confluence. Post‐confluent undifferentiated HT‐29 cells and differentiated enterocyte‐like HT‐29 G− and Caco‐2 cells secrete significant levels of cathepsin D in culture medium, in contrast to post‐confluent differentiated mucin‐secreting HT‐29 MTX cells, which secrete this enzyme at a very low level. The intracellular content and the mRNA level of cathepsin D increase after confluence in the different cell types, particularly in Caco‐2 cells, which intensify the secretion of cathepsin D along with the differentiation process post‐confluence. Membrane‐associated mature cathepsin D was detected in HT‐29 cells but not in Caco‐2 cells. In the different types of cell, pro‐cathepsin D associates with the membrane concomitantly to its binding to an M, 72,000 protein. Membrane association persists after dissociation of the complex in HT‐29 cells but not in Caco‐2 cells. In the mucin‐secreting HT‐29 MTX cells, cathepsin D was immunolocalised to the membrane of mucin vacuoles localised under the brush border. Our results show that cathepsin D can be regulated differently in colon carcinoma cells, and this finding might have specific functional implications for each cell type. © 1996 Wiley‐Liss, Inc.

[1]  F. Real,et al.  Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. , 1995, Journal of cell science.

[2]  V. Debailleul,et al.  Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? , 1995, The Biochemical journal.

[3]  H. Rochefort,et al.  Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. , 1994, Experimental cell research.

[4]  G. Huet,et al.  The state of differentiation of HT‐29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator , 1994, International journal of cancer.

[5]  G. Conner,et al.  Intermolecular association of lysosomal protein precursors during biosynthesis. , 1994, The Journal of biological chemistry.

[6]  J. Wittliff,et al.  Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease. , 1993, Archives of surgery.

[7]  H. de Smedt,et al.  Differences in regulation between nuclear and cytoplasmic Ca2+ in cultured smooth muscle cells. , 1992, The American journal of physiology.

[8]  T. Weaver,et al.  Processing of surfactant protein B proprotein by a cathepsin D-like protease. , 1992, The American journal of physiology.

[9]  H. Geuze,et al.  Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells. , 1991, The Journal of biological chemistry.

[10]  A. Barbat,et al.  Increased growth adaptability to 5‐fluorouracil and methotrexate of HT‐29 sub‐populations selected for their commitment to differentiation , 1991, International journal of cancer.

[11]  H. Geuze,et al.  Mannose 6-phosphate-independent membrane association of cathepsin D, glucocerebrosidase, and sphingolipid-activating protein in HepG2 cells. , 1991, The Journal of biological chemistry.

[12]  A. Barbat,et al.  Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. , 1990, Cancer research.

[13]  H. Rochefort,et al.  Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. , 1990, Cancer research.

[14]  S. Kornfeld,et al.  Mannose 6-phosphate receptors and lysosomal enzyme targeting. , 1989, The Journal of biological chemistry.

[15]  H. Rochefort,et al.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. , 1989, Cancer research.

[16]  H. Rochefort,et al.  In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. , 1988, Cancer research.

[17]  D. Helseth,et al.  Cathepsin D-mediated processing of procollagen: lysosomal enzyme involvement in secretory processing of procollagen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. von Figura,et al.  Biosynthesis and transport of cathepsin D in cultured human fibroblasts , 1983, The Journal of cell biology.

[19]  M. Pinto,et al.  Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture , 1983 .

[20]  K. Figura,et al.  Oligosaccharides in Lysosomal Enzymes , 1981 .